These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9700853)
1. Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes. Reber G; Amiral J; de Moerloose P Thromb Res; 1998 Jul; 91(1):45-7. PubMed ID: 9700853 [No Abstract] [Full Text] [Related]
2. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients. Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128 [TBL] [Abstract][Full Text] [Related]
3. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension. Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658 [TBL] [Abstract][Full Text] [Related]
4. Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy? Barcellona D; Biondi G; Mameli G; Marongiu F Int J Clin Lab Res; 1997; 27(1):76-8. PubMed ID: 9144033 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives. Levine AB; Teppa J; McGough B; Cowchock FS Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613 [TBL] [Abstract][Full Text] [Related]
6. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309 [TBL] [Abstract][Full Text] [Related]
7. Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass : relationship to increased thrombin generation and heparin concentration. Philippou H; Davidson SJ; Mole MT; Pepper JR; Burman JF; Lane DA Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):248-54. PubMed ID: 9974404 [TBL] [Abstract][Full Text] [Related]
8. Measurement of markers of activated coagulation in antithrombin III deficient subjects. Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214 [TBL] [Abstract][Full Text] [Related]
9. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978 [TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2. Lambropoulos AF; Foka Z; Makris M; Daly M; Kotsis A; Makris PE Blood Coagul Fibrinolysis; 1997 Nov; 8(8):485-9. PubMed ID: 9491265 [TBL] [Abstract][Full Text] [Related]
11. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma. Iversen LH; Thorlacius-Ussing O Thromb Res; 1996 Jan; 81(2):253-61. PubMed ID: 8822140 [TBL] [Abstract][Full Text] [Related]
12. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements. Leroy-Matheron C; Gouault-Heilmann M Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241 [TBL] [Abstract][Full Text] [Related]
13. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823 [TBL] [Abstract][Full Text] [Related]
14. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912 [TBL] [Abstract][Full Text] [Related]
15. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement. Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237 [TBL] [Abstract][Full Text] [Related]
16. Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation. Asakura H; Shiratori Y; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T Acta Haematol; 1993; 89(1):22-5. PubMed ID: 8480481 [TBL] [Abstract][Full Text] [Related]
17. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Boneu B; Bes G; Pelzer H; Sié P; Boccalon H Thromb Haemost; 1991 Jan; 65(1):28-31. PubMed ID: 2024237 [TBL] [Abstract][Full Text] [Related]